|
|
 |
|
Viewing report
|
|
|
|
U.S. Life Science Mass Spectrometry Markets
Frost & Sullivan, June 2006
This Frost & Sullivan research service entitled U.S. Life Science Mass Spectrometry Market provides a market forecast for mass spectrometers, taking into account two or three items that are included in the study. In this research, Frost & Sullivan's expert analysts thoroughly examine the mass spectrometry market, composed of the following: single quadrupole, triple quadrupole, ion trap, MALDI, and high resolution mass spectrometry.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this analysis:
- Drug Discovery Technologies
- Clinical Diagnostics
- Pharmaceutical/Biotech
- Life sciences IT
Technologies
The following technologies are covered in this research:
- Biomarker discovery
- Drug compound development
- Imaging
Market Overview
Mass spetrometry is a tool that is growing in use as the the market for tailored drugs and the need to identify biomarkers increases. The completion of the human genome project has ushered in a new era of research focused on the protein products encoded by the genome. This era will be far more complicated to understand, and will require far more powerful instruments that can provide clues as to protien structure and ultimately, function. In addition, mass spectrometry is capable of providing data for the construction of 3-D models of drug compounds and other biomolecules, allowing scientists to identify targets for drugs and helping scientists develop more effective drugs based on structure. Predisposition to disease through biomarker analysis, diagnosis, and prognosis of disease as to stage, are all elements of medical visitis that will improve the type and timing of treament avaiable to patients through the use of mass spectrometry.
This research service evaluates the U.S. life science mass spectrometry market. This study identifies market drivers and restraints, technology and market trends, and provides revenue forecasts for individual market segments and for the overall mass spectrometry market from 2006 to 2012 based on these measures. In addition, key challenges facing the industry and potential strategies to overcome these impediments to growth are discussed.
The mass spectrometry market is segmented into five categories, including the single quadrupole, triple quadrupole, ion trap, MALDI, and high resolution mass spectrometry markets. This analysis highlights the fast growing markets, such as the MALDI and high resolution segments, and discusses the slow growth in other areas such as the single quadrupole segment. These market segments not only vary by technology, but also by applications for which they can be employed. The extension from basic research to clinical research laboratories and to clinical diagnostics has increased the market potential for the mass spectrometry market.
|
|
|
|
